Lpl Financial LLC Axsome Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 16,372 shares of AXSM stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,372

Previous 14,881 10.02%

Holding current value

$1.48 Million

Previous $1.2 Million 22.89%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$78.93 - $95.84 $117,684 - $142,897	1,491 Added 10.02%	16,372 $1.47 Million
Q2 2024 Aug 07, 2024	SELL	$65.72 - $80.5 $75,840 - $92,897	-1,154 Reduced 7.2%	14,881 $1.2 Million
Q1 2024 May 10, 2024	BUY	$69.39 - $97.64 $391,359 - $550,689	5,640 Added 54.26%	16,035 $1.28 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $108,868 - $158,524	1,896 Added 22.31%	10,395 $827,000
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $6,855 - $8,138	-99 Reduced 1.15%	8,499 $593,000
Q2 2023 Jul 31, 2023	SELL	$58.41 - $90.35 $2,920 - $4,517	-50 Reduced 0.58%	8,598 $617,000
Q1 2023 May 10, 2023	BUY	$58.39 - $75.0 $59,207 - $76,050	1,014 Added 13.28%	8,648 $533,000
Q4 2022 Feb 07, 2023	SELL	$39.94 - $79.72 $68,337 - $136,400	-1,711 Reduced 18.31%	7,634 $588,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $17,561 - $34,016	487 Added 5.5%	9,345 $417,000
Q2 2022 Aug 12, 2022	SELL	$21.74 - $46.75 $31,588 - $67,927	-1,453 Reduced 14.09%	8,858 $339,000
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $47,020 - $82,117	-1,984 Reduced 16.14%	10,311 $427,000
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $33,125 - $46,785	1,079 Added 9.62%	12,295 $465,000
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $146,398 - $501,915	7,353 Added 190.34%	11,216 $370,000
Q2 2021 Aug 13, 2021	BUY	$50.63 - $73.5 $195,583 - $283,930	3,863 New	3,863 $261,000

Others Institutions Holding AXSM

# of Institutions

326

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Axsome Therapeutics, Inc. Transaction History